Overview
With more than 25.8 million people in the United States suffering from diabetes, drug companies are always looking to increase their profits by introducing new Type 2 Diabetes treatments. By providing new treatment options for this ever-growing segment of the population, drug companies hope to hit the latest blockbuster drug.
Unfortunately, a new class of Type 2 Diabetes treatment called incretin mimetics, many of which have turned out to be blockbusters, have also turned out to carry risks of serious side effects such as pancreatitis, pancreatic cancer, and thyroid cancer. Drugs in this class include Januvia, Byetta, Victoza, Onglyza, Tradjenta, and others.
Individuals that have been injured by these drugs are joining lawsuits to receive compensation for their injuries. Contact us today to see if you qualify to join.
Blog Posts
Consumer Reports Calls for Hip Manufacturers to Provide Warranties
In the past years, there has been a huge increase in the number of young people getting hip and knee replacements. In the past, these devices were reserved for the elderly, but as more and more people live and want to maintain active lifestyles, these implants are becoming an option for the young. In fact,…
British Medical Journal Reports Ongoing Problems with Metal on Metal Hip Implants
In a February 2012 issue of the journal BMJ, scientists reported on the problems common to all metal on metal hip implants. First, revision rates with metal on metal hip implants are much higher than with other types of implants. Second, metal poisoning is an unfortunate reality of these implants as well. The metal used…
What Happens When a Manufacturer Issues a Recall?
With most metal on metal hip implants having reports of complications, you may be wondering what steps you should take if you have received an implant. If you suspect that your hip implant may be causing complications or may be one of those subject to a recall, first contact your doctor’s office to get more…
